Resolian

Resolian

Resolian (Alliance Pharma) is a leading global Contract Research Organization (CRO) providing specialized services in GxP and non-regulated bioanalysis, drug metabolism/pharmacokinetic (DMPK), and GMP CMC analytical and materials science. Comprised of the former Alliance Pharma Inc, Drug Development Solutions Ltd, and Denali Medpharma labs and powered by a team of more than 500 experts across the US, UK, Australia, and China, Resolian supports pharma and biotech companies’ programs throughout the entire drug development continuum.

Resolian's specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, and drug metabolism. These solutions are delivered through Resolian's dedicated global laboratories, equipped with state-of-the-art technology and ready to meet client needs for preclinical studies as well as regional or global clinical programs.

ADME (Absorption/Distribution/Metabolism/Excretion), CRO—Contract Research Organization, GLP—Good Laboratory Practice Services, In Vitro, In Vivo, LC/MS—Liquid Chromatography/Mass Spectroscopy, Metabolism Studies, Nonclinical, Preclinical, Bioanalytical Services, Biomarkers, Research/Testing